CD20 deficiency in humans results in impaired T cell–independent antibody responses

CD20 was the first B cell differentiation antigen identified, and CD20-specific mAbs are commonly used for the treatment of B cell malignancies and autoantibody-mediated autoimmune diseases. Despite this the role of CD20 in human B cell physiology has remained elusive. We describe here a juvenile pa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kuijpers, Taco W., Bende, Richard J., Baars, Paul A., Grummels, Annette, Derks, Ingrid A.M., Dolman, Koert M., Beaumont, Tim, Tedder, Thomas F., van Noesel, Carel J.M., Eldering, Eric, van Lier, René A.W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2009
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2798692/
https://ncbi.nlm.nih.gov/pubmed/20038800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI40231
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak